The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer Cameron P. CapperJames M. RaeRichard J. Auchus Review 11 March 2016 Pages: 149 - 164
TERT Promoter Mutations in Thyroid Cancer Ali S. AlzahraniRawan AlsaadiBakr Bin Sadiq Review 22 February 2016 Pages: 165 - 177
Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study Tess V. ClendenenKathryn HertzmarkAnne Zeleniuch-Jacquotte Original Paper 29 February 2016 Pages: 178 - 187
pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer Mark YarchoanChangqing MaMarcia S. Brose Original Paper 18 March 2016 Pages: 188 - 195
CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy Huiying SunSanjay N. MediwalaMarco Marcelli Original Paper 08 March 2016 Pages: 196 - 210
Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide Matthias KroissTimo Deutschbeinon behalf of the German Adrenocortical Carcinoma Study Group Original Paper 09 March 2016 Pages: 211 - 218